Table 1. Cases used in this study.
| Case | n | Age | Braak stage |
|---|---|---|---|
| Single staining | |||
| con | 4 | 57-74 | 0-3 |
| AD | 6 | 54-87 | 4-6 |
| PiD | 3 | 41-70 | - |
| MAPT mutation carrier | 5 | 49-68 | - |
| PSP | 2 | 67,72 | - |
| Double staining | |||
| con | 1 | 66 | - |
| AD | 8 | 64-87 | 5-6 |
| PiD | 5 | 54-82 | - |
| MAPT mutation carrier | 1 | 51 | - |
| WB | |||
| con | 7 | 41-84 | 1 |
| AD | 7 | 72-85 | 4-6 |
| qPCR | |||
| con | 11 | 80-93 | 1-3 |
| AD | 11 | 75-94 | 3-6 |
con, control; AD, Alzheimer’s disease; MAPT, microtubule associated protein tau; PiD, Pick’s disease; PSP, progressive supranuclear palsy; WB, Western blot; qPCR, quantitative PCR.